Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Moderna Stock Overvalued?

TheMotleyFool

0 0

Moderna (NASDAQ: MRNA) stock skyrocketed last year. Its momentum has carried over into 2021 as well. After its tremendous gains, the biotech's market cap is now well over $60 billion. In this Motley Fool Live video recorded on Feb. 3, 2021, Fool.com contributors Keith Speights and Brian Orelli talk about whether Moderna stock is now overvalued after its remarkable run.

Source Fool.com

Like: 0

MRNA

Share